Conduct Phase-III clinical trial: CDSCO Panel tells Abbott on Ademetionine for Injection 400mg Dr. Divya Colin10 April 2024 6:00 PM ISTNew Delhi: Responding to the proposal of import and marketing of Ademetionine for injection 400mg, the Subject Expert Committee (SEC) functional under...
Conduct Randomized Control Phase III CT in Indian Population: CDSCO Panel Tells Pfizer on Rimegepant Dr. Divya Colin15 March 2024 6:00 PM ISTNew Delhi: Rejecting the proposal for local Phase III clinical trial waivers, the Subject Expert Committee (SEC) functional under the Central Drug...
Novel Single-Dose Dengue Vaccine Shows High Efficacy in Phase 3 Trial Dr Riya Dave2 Feb 2024 11:15 AM ISTIn a breakthrough development, the Butantan-Dengue Vaccine (Butantan-DV), an investigational single-dose, live, attenuated, tetravalent vaccine...
Submit Modified Informed Consent Form with details: CDSCO Panel Tells Sanofi om Multiple Sclerosis Drug Tolebrutinib Dr. Divya Colin21 Jan 2024 6:00 PM ISTNew Delhi: Reviewing the Phase III clinical study protocol of Tolebrutinib presented by the drug major Sanofi, the Subject Expert Committee (SEC)...
Serum Institute of India Gets CDSCO Panel Nod to Study Yellow Fever Vaccine Dr. Divya Colin19 Jan 2024 6:00 PM ISTNew Delhi: The vaccine maker Serum Institute of India has got approval from the Subject Expert Committee (SEC) functional under the Central Drug...
Linaclotide Proves Effective for Pediatric Constipation Dr Riya Dave16 Jan 2024 7:00 AM ISTIn a significant development for pediatric gastroenterology, linaclotide, a guanylate cyclase C agonist, has been granted approval by the US Food and...
Bayer Pharma gets CDSCO Panel nod to study Asundexian 50mg tablets Dr. Divya Colin29 Dec 2023 5:30 PM ISTNew Delhi: Bayer Pharmaceutical has got approval from the Subject Expert Committee (SEC) functional under the Central Drug Standard Control...
Roche Gets CDSCO Panel Nod to Study anti-cancer Drug Inavolisib Dr. Divya Colin12 Dec 2023 6:00 PM ISTNew Delhi: The drug major Roche has got approval from the Subject Expert Committee (SEC) functional under the Central Drug Standard Control...
Novartis Gets CDSCO Panel Nod to study Remibrutinib to treat chronic spontaneous urticaria Dr. Divya Colin8 Dec 2023 6:00 PM ISTNew Delhi: The drug major Novartis has got approval from the Subject Expert Committee (SEC) functional under the Central Drug Standard Control...
BDR Pharma Gets CDSCO Panel Nod To Study Vonoprazan Tablets Dr. Divya Colin15 Nov 2023 6:30 PM ISTNew Delhi: The drug major BDR Pharma has got approval from the Subject Expert Committee (SEC) functional under the Central Drug Standard Control...
Atrasentan found superior to placebo for proteinuria reduction in the Phase 3 Trial for IgA Nephropathy. Dr Kartikeya Kohli4 Nov 2023 11:15 AM ISTIgA nephropathy (IgAN) is an autoimmune disorder wherein clusters of antibodies get deposited in the kidneys, leading to inflammation and damage to...
Abbott Gets CDSCO Panel Nod to Study Dydrogesterone Modified Release Tablets Dr. Divya Colin10 Oct 2023 6:00 PM ISTNew Delhi: The Subject Expert Committee (SEC) functional under the Central Drug Standard Control Organization (CDSCO) has given its nod to drug major...
